[Full text] LncRNA SLC16A1-AS1 Suppresses Cell Proliferation

1
1Department of Gynecology, Heping Hospital Affiliated to Changzhi Medical College, Changzi, Shanxi Province, 046000, People’s Republic of China;
2Department of Clinical Laboratory, Heping Hospital Affiliated to Changzhi Medical College, Changzi, Shanxi Province, 046000, People’s Republic of China;
3Department of Obstetrics, Heping Hospital Affiliated to Changzhi Medical College, Changzi, Shanxi Province, 046000, People’s Republic of China
Correspondence: Shuangling Jin
Department of Gynecology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi City, Shanxi Province, 046000, People’s Republic of China
Background: SLC16A1-AS1 has been characterized as an oncogenic long non-coding (lncRNA) in breast cancer and bladder cancer, while its role in cervical squamous cell carcinoma (CSCC) is unknown.

Related Keywords

China , Changzhi , Shanxi , United States , Shanghai , , Ethics Committee , Heping Hospital Affiliated To Changzhi Medical College , Promega Corporation , Protein Miniprep Zymo Research , Heping Hospital Affiliated , Changzhi Medical College , Quantitect Reverse Transcription Kit , Spin Protein Miniprep , Zymo Research , Counting Kit , சீனா , ஒன்றுபட்டது மாநிலங்களில் , ஷாங்காய் , நெறிமுறைகள் குழு , ப்ரொமெகா நிறுவனம் , எண்ணும் கிட் ,